Sort
64,565 grants matching “drug discovery”
Antiviral & Antimicrobial Countermeasures Discovery and Development Core
$1,216,129Colleen B Jonsson · University Of Tennessee Health Sci Ctr · UC7 · FY2023 · AI
A Shared Neuroscience Platform for National Dissemination and Training in Brain Organogenesis, Behavioral and Brain Disease Models, Viral Vectors, and Imaging Technologies
$1,216,033Mehrdad Shamloo · Stanford University · U24 · FY2024 · NS
HTS enabled examination of drug combinations
$1,215,806Craig Thomas · National Center For Advancing Translational Sciences · ZIA · FY2025 · TR
DNA Topoisomerases as Target of Action of Anticancer Drugs
$1,215,655Yves Pommier · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Center for Computational Mass Spectrometry
$1,215,402Pavel A Pevzner · University Of California, San Diego · P41 · FY2017 · GM
Center for Computational Mass Spectrometry
$1,215,402Pavel A Pevzner · University Of California, San Diego · P41 · FY2018 · GM
The MetaCyc and BioCyc Pathway/Genome Databases [SRI Proposal ECU 10-626]
$1,215,153Peter D Karp · Sri International · R01 · FY2014 · GM
Regulatory landscape of the human genome: comparative and evolutionary analysis.
$1,215,077Ivan Ovcharenko · National Library Of Medicine · ZIA · FY2020 · LM
Rhythmicity and Synchrony in the Basal Ganglia
$1,215,025Dalton James Surmeier · Northwestern University At Chicago · P50 · FY2011 · NS
Antimicrobial Oligomers for BioDefense and Emerging Food Borne Infectious Disease
$1,215,012Gregory N. Tew · University Of Massachusetts Amherst · U01 · FY2010 · AI
Liver-Targeted Prodrugs for the Treatment of Hepatitis C
$1,214,585Metabasis Therapeutics, Inc. · R44 · FY2003 · AI
Genetic susceptibility to unrelated donor stem cell transplant-related mortality
$1,214,404Theresa E Hahn · Roswell Park Cancer Institute Corp · R01 · FY2012 · HL
DNA repair deficient cells for analysis
$1,214,292Jay George · Trevigen, Inc. · R44 · FY2011 · GM
PET ligand discovery for arginine vasopressin
$1,214,143Steven H Liang · Emory University · R01 · FY2023 · MH
Novel Antiangiogenic Peptides for Treatment of Exudative AMD
$1,213,468Nader Sheibani · University Of Wisconsin-Madison · R24 · FY2017 · EY
Optimization and evaluation of novel benzimidazoles for the treatment of Alzheimer's Disease
$1,213,070Kevin Hodgetts · Brigham And Women'S Hospital · U01 · FY2023 · AG
Medicinal Chemistry and Lead Development Core
$1,213,036Joseph A Maddry · University Of Alabama At Birmingham · U19 · FY2014 · AI
NIMH TOXICOLOGICAL EVALUATIONS OF NOVEL LIGANDS
$1,212,909Hannah Ng · Sri International · N01 · FY2009 · MH
Predictive Models for Small-Molecule Accumulation in Gram-Negative Bacteria
$1,212,566Derek S Tan · Sloan-Kettering Inst Can Research · R01 · FY2019 · AI
Structural and chemical biology of membrane proteins
$1,211,678Anirban Banerjee · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2015 · HD
Systems Biology of Tumor Progression and Drug Resistance
$1,211,593Andrea Califano · Columbia University Health Sciences · U01 · FY2012 · CA
Medicinal Chemistry
$1,211,426Joseph M Ready · Ut Southwestern Medical Center · U54 · FY2019 · CA
Raman Flow Cytometry for Diagnostics and Drug Discovery
$1,211,417John P Nolan · La Jolla Bioengineering Institute · R01 · FY2008 · EB
DNA Topoisomerases as nuclear and mitochondrial targets of Anticancer Drugs
$1,211,401Yves Pommier · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs
$1,211,401Yves Pommier · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA